These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12842316)

  • 1. Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis.
    Brandeau ML; Zaric GS; Richter A
    J Health Econ; 2003 Jul; 22(4):575-98. PubMed ID: 12842316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic resource allocation for epidemic control in multiple populations.
    Zaric GS; Brandeau ML
    IMA J Math Appl Med Biol; 2002 Dec; 19(4):235-55. PubMed ID: 12828363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
    Elbasha EH
    Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramsey waits: allocating public health service resources when there is rationing by waiting.
    Gravelle H; Siciliani L
    J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting to changes in health: implications for cost-effectiveness analysis.
    Sharma R; Stano M; Haas M
    J Health Econ; 2004 Mar; 23(2):335-51. PubMed ID: 15019760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.
    Elbasha EH; Messonnier ML
    Health Econ; 2004 Jan; 13(1):21-35. PubMed ID: 14724891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resource allocation analysis for international cooperation program for HIV/AIDS prevention and control].
    Li H; Xue H; Liu H; Guo HY; Zhang H; Sun JP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):888-91. PubMed ID: 19141222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allocating health care resources when people are risk averse with respect to life time.
    Hoel M
    Health Econ; 2003 Jul; 12(7):601-8. PubMed ID: 12825211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological resource allocation in Germany.
    Hartmann M; Kath R; Gundermann C
    Onkologie; 2008 Mar; 31(3):85-9. PubMed ID: 18322410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming.
    Tanner MW; Sattenspiel L; Ntaimo L
    Math Biosci; 2008 Oct; 215(2):144-51. PubMed ID: 18700149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of biotechnology-based healthcare products for prioritization in Indian context.
    Visalakshi S; Mohan S
    Int J Technol Assess Health Care; 2002; 18(3):718-27. PubMed ID: 12391962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of epidemic phase on the cost effectiveness of a prevention intervention for sexually transmitted infection: an exploratory analysis.
    Chesson HW; White PJ
    Sex Transm Infect; 2007 Aug; 83 Suppl 1():i25-29. PubMed ID: 17314128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource allocation for community-based therapy.
    Murchland S; Wake-Dyster W
    Disabil Rehabil; 2006 Nov; 28(22):1425-32. PubMed ID: 17071575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective allocation of government funds to prevent HIV infection.
    Cohen DA; Wu SY; Farley TA
    Health Aff (Millwood); 2005; 24(4):915-26. PubMed ID: 16136633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.